bioRxiv Science⌕ Search

Biology subjects

Villalta, M.

Publications and source records attributed to Villalta, M..

4 recordsLinked to original sources

Experimental validation of graded arithmetic and linguistic working-memory tasks using behavioral and cerebral hemodynamic measures

Graded cognitive tasks are relevant only when increasing nominal difficulty produces measurable changes in performance and a convergent physiological response. This study evaluated a five-level arithmetic paradigm and a five-level linguistic paradigm designed to engage working memory through separate exposure, retention, and response intervals. Thirty-eight healthy young adults completed both paradigms. Behavioral manipulation validity was assessed from accuracy and completion time; linguistic item-level responses were additionally modeled to detect nonlinear floor effects. Bilateral middle cerebral artery blood-flow velocity was recorded with transcranial Doppler ultrasonography. Baseline-normalized mean velocity change was the primary physiological endpoint, with positive and net area under the curve, peak response, time to peak, and early slope as secondary endpoints. Accuracy declined and completion time increased strongly across levels in both domains, with a substantially steeper accuracy decline in the linguistic paradigm. Although the levels were nominally ordered, the higher linguistic levels did not produce equidistant increases due to the ground effect. Transcranial Doppler models showed significant level-dependent changes in mean velocity, positive and net area under the curve, time to peak, and early slope. However, domain-by-level and domain-by-level-by-hemisphere interactions were not significant. Behavioral and physiological measures therefore converged mainly at the level of the graded experimental manipulation, rather than as distinct domain-specific or lateralized hemodynamic signatures. These findings lend support to paradigms as a multimodal framework for manipulating cognitive load experimentally, while also indicating upper-level language saturation and physiological quality-control decisions that should guide further improvement.

neuroscience↗

The Genome of the American Dog Tick (Dermacentor variabilis)

The American dog tick (Dermacentor variabilis) is a vector of zoonotic pathogens in North America that poses emerging threats to public health. Despite its medical importance, genomic resources for D. variabilis remain scarce. Leveraging long-read nanopore sequencing, we generated a high-quality genome assembly for D. variabilis with a final size of 2.15 Gb, an N50 of 445 kb, and a BUSCO completeness score of 95.2%. Comparative BUSCO analyses revealed fewer duplicate genes in our assembly than in other Dermacentor genomes, indicating improved haplotype resolution. The mitochondrial genome, assembled as a single circular contig, clustered monophyletically with D. variabilis isolates from the Upper Midwest, corroborating regional phylogenetic relationships. Repetitive element analysis identified 61% of the genome as repetitive, dominated by LINEs and LTR elements, with 24% remaining unclassified, underscoring the need for further exploration of transposable elements in tick genomes. Gene annotation predicted 21,722 putative genes, achieving a protein BUSCO completeness of 80.88%. Additionally, genome-wide methylation analysis revealed 9.9% global 5mC methylation, providing the first insights into epigenetic modifications in D. variabilis. Further, nanopore sequencing detected Rickettsia montanensis and a non-pathogenic Francisella-like endosymbiont. These findings expand our understanding of tick genomics and epigenetics, offering valuable resources for comparative studies and evolutionary analyses.

genomics↗

High efficacy of therapeutic equine hyperimmune antibodies against SARS CoV-2 variants of concern

SARS-CoV-2 variants of concern (VoC) show reduced neutralization by vaccine-induced and therapeutic monoclonal antibodies. We tested therapeutic equine polyclonal antibodies (pAbs) against four VoC (alpha, beta, epsilon and gamma). We show that equine pAbs efficiently neutralize VoC, suggesting they are an effective, broad coverage, low-cost and a scalable COVID-19 treatment.

microbiology↗

Development and pre-clinical characterization of two therapeutic equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19

In the current global emergency due to SARS-CoV-2 outbreak, passive immunotherapy emerges as a promising treatment for COVID-19. Among animal-derived products, equine formulations are still the cornerstone therapy for treating envenomations due to animal bites and stings. Therefore, drawing upon decades of experience in manufacturing snake antivenom, we developed and preclinically evaluated two anti-SARS-CoV-2 polyclonal equine formulations as potential alternative therapy for COVID-19. We immunized two groups of horses with either S1 (anti-S1) or a mixture of S1, N, and SEM mosaic (anti-Mix) viral recombinant proteins. Horses reached a maximum anti-viral antibody level at 7 weeks following priming, and showed no major adverse acute or chronic clinical alterations. Two whole-IgG formulations were prepared via hyperimmune plasma precipitation with caprylic acid and then formulated for parenteral use. Both preparations had similar physicochemical and microbiological quality and showed ELISA immunoreactivity towards S1 protein and the receptor binding domain (RBD). The anti-Mix formulation also presented immunoreactivity against N protein. Due to high anti-S1 and anti-RBD antibody content, final products exhibited high in vitro neutralizing capacity of SARS-CoV-2 infection, 80 times higher than a pool of human convalescent plasma. Pre-clinical quality profiles were similar among both products, but clinical efficacy and safety must be tested in clinical trials. The technological strategy we describe here can be adapted by other producers, particularly in low- and middle-income countries.

microbiology↗